Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Journal of Clinical Psychology
|
January 1, 1985
Depression and the wish to be held
N Stein, M Sanfilipo
Schizophrenia Research
|
October 1, 1991
Amphetamine response and duration of illness in schizophrenia
B Angrist, M Sanfilipo, A Wolkin
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 1, 1993
A placebo-controlled trial of L-dopa/carbidopa in early cocaine abstinence
R Wolfsohn, M Sanfilipo, B Angrist
Clinical Neuropharmacology
|
June 8, 2001
Cardiovascular effects of 0.5 milligrams per kilogram oral d-amphetamine and possible attenuation by haloperidol
B Angrist, M Sanfilipo, A Wolkin
Clinical Neuropharmacology
|
July 15, 2000
Akathisia and exacerbation of psychopathology: a preliminary report
E J Duncan, L A Adler, M Stephanides, et al.
Archives of General Psychiatry
|
December 1, 1992
Negative symptoms and hypofrontality in chronic schizophrenia
A Wolkin, M Sanfilipo, A P Wolf, et al.
Journal of Neural Transmission. General Section
|
January 1, 1994
Persistent psychosis after reduction in pre- and post-synaptic dopaminergic function
A Wolkin, E Duncan, M Sanfilipo, et al.
Journal of Clinical Psychopharmacology
|
August 1, 1992
Central nervous system stimulants as symptomatic treatments for AIDS-related neuropsychiatric impairment
B Angrist, M d'Hollosy, M Sanfilipo, et al.
Biological Psychiatry
|
October 15, 1993
Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics
E Duncan, A Wolkin, B Angrist, et al.
Psychiatry Research
|
October 1, 1991
Importance of pharmacologic control in PET studies: effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia
E J Bartlett, A Wolkin, J D Brodie, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Journal of Clinical Psychology
|
January 1, 1985
Depression and the wish to be held
N Stein, M Sanfilipo
Schizophrenia Research
|
October 1, 1991
Amphetamine response and duration of illness in schizophrenia
B Angrist, M Sanfilipo, A Wolkin
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 1, 1993
A placebo-controlled trial of L-dopa/carbidopa in early cocaine abstinence
R Wolfsohn, M Sanfilipo, B Angrist
Clinical Neuropharmacology
|
June 8, 2001
Cardiovascular effects of 0.5 milligrams per kilogram oral d-amphetamine and possible attenuation by haloperidol
B Angrist, M Sanfilipo, A Wolkin
Clinical Neuropharmacology
|
July 15, 2000
Akathisia and exacerbation of psychopathology: a preliminary report
E J Duncan, L A Adler, M Stephanides, et al.
Archives of General Psychiatry
|
December 1, 1992
Negative symptoms and hypofrontality in chronic schizophrenia
A Wolkin, M Sanfilipo, A P Wolf, et al.
Journal of Neural Transmission. General Section
|
January 1, 1994
Persistent psychosis after reduction in pre- and post-synaptic dopaminergic function
A Wolkin, E Duncan, M Sanfilipo, et al.
Journal of Clinical Psychopharmacology
|
August 1, 1992
Central nervous system stimulants as symptomatic treatments for AIDS-related neuropsychiatric impairment
B Angrist, M d'Hollosy, M Sanfilipo, et al.
Biological Psychiatry
|
October 15, 1993
Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics
E Duncan, A Wolkin, B Angrist, et al.
Psychiatry Research
|
October 1, 1991
Importance of pharmacologic control in PET studies: effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia
E J Bartlett, A Wolkin, J D Brodie, et al.
Page
of 2